Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy

ISSN： 1742-5247

Source： Expert Opinion on Drug Delivery, Vol.5, Iss.12, 2008-12, pp. : 1301-1311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strategies for tumor-directed delivery of siRNA

By Chowdhury Ezharul Hoque

Expert Opinion on Drug Delivery, Vol. 8, Iss. 3, 2011-03 ,pp. : 389-401

Informa Healthcare

Access to resources Recommend Favorite

Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool

By Kaneda Yasufumi

Expert Opinion on Drug Delivery, Vol. 7, Iss. 9, 2010-09 ,pp. : 1079-1093

Informa Healthcare

Access to resources Recommend Favorite

Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines

By Deering Raquel P Kommareddy Sushma Ulmer Jeffrey B Brito Luis A Geall Andrew J

Expert Opinion on Drug Delivery, Vol. 11, Iss. 6, 2014-06 ,pp. : 885-899

Informa Healthcare

Access to resources Recommend Favorite

ICS-283: a system for targeted intravenous delivery of siRNA

By Schiffelers Raymond M Storm Gert

Expert Opinion on Drug Delivery, Vol. 3, Iss. 3, 2006-05 ,pp. : 445-454

Informa Healthcare

Access to resources Recommend Favorite

Nanocarrier systems for delivery of siRNA to ovarian cancer tissues

By Fathabadi Eshrat Gharaei Shelling Andrew N. Al-Kassas Raida

Expert Opinion on Drug Delivery, Vol. 9, Iss. 7, 2012-07 ,pp. : 743-754

Informa Healthcare

Access to resources Recommend Favorite